BeOne Medicines (ONC) Revenue Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) Revenue Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 54.05% |
| 10 | Revolution Medicines | 37.31 Bn | 37.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.07% |
| Dec 31, 2025 | 57.96% |
| Sep 30, 2025 | 53.88% |
| Jun 30, 2025 | 56.74% |
| Mar 31, 2025 | 53.88% |
| Dec 31, 2024 | 74.03% |
| Sep 30, 2024 | 69.29% |
| Jun 30, 2024 | 83.66% |
| Mar 31, 2024 | 7.45% |
| Dec 31, 2023 | 85.06% |
| Sep 30, 2023 | 104.71% |
| Jun 30, 2023 | 108.54% |
| Mar 31, 2023 | 104.89% |
| Dec 31, 2022 | 88.34% |
| Sep 30, 2022 | 97.73% |
| Jun 30, 2022 | 11.97% |
| Mar 31, 2022 | 57.94% |
| Dec 31, 2021 | 53.93% |
| Sep 30, 2021 | 56.17% |
| Jun 30, 2021 | 41.62% |